Logiscreen

VistaGen Therapeutics Inc

$0.54
Market Cap 21.22M
ROE -109.7%
Gross Margin 100.0%
Debt/Equity 0.0
Current Ratio 4.7
Revenue QoQ 29.5%
EPS QoQ -0.0%
F-Score 3

About

VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen's drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.32
vs median 34.32
P/B
0.42
vs median 2.21
ROE
-1.10
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics